Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stevo Julius

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Journal of Hypertension|March 19, 2005
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudyMichael H Olsen, Eigil Fossum, Aud Høieggen, et al.
The New England Journal of Medicine|March 16, 2006
Feasibility of treating prehypertension with an angiotensin-receptor blockerStevo Julius, Shawna D Nesbitt, Brent M Egan, et al.
Blood Pressure|January 6, 2021
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertensionEirik Olsen, Björn Holzhauer, Stevo Julius, et al.
Lancet (London, England)|June 23, 2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialStevo Julius, Sverre E Kjeldsen, Michael Weber, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Medical Therapies for Heart Failure With Preserved Ejection FractionSverre E Kjeldsen, Thomas G von Lueder, Otto A Smiseth, et al.
JAMA|September 14, 2006
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertensionPeter M Okin, Kristian Wachtell, Richard B Devereux, et al.
American Journal of Hypertension|August 8, 2023
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of EvidenceKaja Sevre, Aurora Rist, Kristian Wachtell, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
European Journal of Internal Medicine|October 21, 2023
The current best drug treatment for hypertensive heart failure with preserved ejection fractionAurora Rist, Kaja Sevre, Kristian Wachtell, et al.
JAMA|November 18, 2004
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular eventsPeter M Okin, Richard B Devereux, Sverker Jern, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Journal of Hypertension|March 19, 2005
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudyMichael H Olsen, Eigil Fossum, Aud Høieggen, et al.
The New England Journal of Medicine|March 16, 2006
Feasibility of treating prehypertension with an angiotensin-receptor blockerStevo Julius, Shawna D Nesbitt, Brent M Egan, et al.
Blood Pressure|January 6, 2021
Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertensionEirik Olsen, Björn Holzhauer, Stevo Julius, et al.
Lancet (London, England)|June 23, 2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialStevo Julius, Sverre E Kjeldsen, Michael Weber, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Medical Therapies for Heart Failure With Preserved Ejection FractionSverre E Kjeldsen, Thomas G von Lueder, Otto A Smiseth, et al.
JAMA|September 14, 2006
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertensionPeter M Okin, Kristian Wachtell, Richard B Devereux, et al.
American Journal of Hypertension|August 8, 2023
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of EvidenceKaja Sevre, Aurora Rist, Kristian Wachtell, et al.
Journal of the American College of Cardiology|March 19, 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE studyStevo Julius, Michael H Alderman, Gareth Beevers, et al.
European Journal of Internal Medicine|October 21, 2023
The current best drug treatment for hypertensive heart failure with preserved ejection fractionAurora Rist, Kaja Sevre, Kristian Wachtell, et al.
JAMA|November 18, 2004
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular eventsPeter M Okin, Richard B Devereux, Sverker Jern, et al.
Pageof 12